Nathaniel Weygant

2.1k citations

55 papers · 1.5k indexed · h-index 26

Co-authors: Dongfeng Qu Courtney W. Houchen Parthasarathy Chandrakesan Randal May Sripathi M. Sureban Naushad Ali William L. Berry Stan Lightfoot
Topics: Cancer Cells and Metastasis (25 papers)Pancreatic and Hepatic Oncology Research (7 papers)Cancer Genomics and Diagnostics (7 papers)
Cited by: Oncology Cancer Research Cell Biology
Journals: Gastroenterology PLoS ONE Cancer Research
Partner nations: United States China Germany

In The Last Decade

Nathaniel Weygant

54 papers receiving 1.5k citations

Peers

Countries citing papers authored by Nathaniel Weygant

Since Specialization

Citations

This map shows the geographic impact of Nathaniel Weygant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathaniel Weygant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathaniel Weygant more than expected).

Fields of papers citing papers by Nathaniel Weygant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathaniel Weygant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathaniel Weygant. The network helps show where Nathaniel Weygant may publish in the future.

Co-authorship network of co-authors of Nathaniel Weygant

This figure shows the co-authorship network connecting the top 25 collaborators of Nathaniel Weygant. A scholar is included among the top collaborators of Nathaniel Weygant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathaniel Weygant. Nathaniel Weygant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Triptolide targets PPP2CA/ITGA5 axis to suppress lactate-driven ovarian cancer progression 2025 ·Chinese Medicine ·(unknown),(unknown),(unknown),Nathaniel Weygant,Yi Lai,Dan Ru,(unknown),You Wang,He Li	0
2	Applications of organoid technology to brain tumors 2023 ·CNS Neuroscience & Therapeutics ·Jie Wen,Fangkun Liu,Quan Cheng,Nathaniel Weygant,Xisong Liang,Fan Fan,Chuntao Li,Liyang Zhang,Zhixiong Liu	23
3	DCLK1 and tuft cells: Immune-related functions and implications for cancer immunotherapy 2023 ·Critical Reviews in Oncology/Hematology ·(unknown),Nathaniel Weygant,(unknown),Yi Lai,He Li	3
4	Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma 2022 ·Technology in Cancer Research & Treatment ·(unknown),(unknown),Ling Duan,Nathaniel Weygant,Guangyu An,Bin Hu,Jiannan Yao	4
5	Emerging Prospects for the Study of Colorectal Cancer Stem Cells usingPatient-derived Organoids 2022 ·Current Cancer Drug Targets ·(unknown),(unknown),(unknown),Zhiyun Cao,Nathaniel Weygant	4
6	Differential Dermatologic Adverse Events Associated With Checkpoint Inhibitor Monotherapy and Combination Therapy: A Meta-Analysis of Randomized Control Trials 2021 ·Frontiers in Pharmacology ·Yang Ge,Huiyun Zhang,Nathaniel Weygant,Jiannan Yao	2
7	DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization 2020 ·Molecular Cancer Therapeutics ·Parthasarathy Chandrakesan,Janani Panneerselvam,Randal May,Nathaniel Weygant,Dongfeng Qu,William L. Berry,(unknown),Ben Z. Stanger,Chinthalapally V. Rao,Michael S. Bronze,Courtney W. Houchen	27
8	Huoxin pill attenuates myocardial infarction-induced apoptosis and fibrosis via suppression of p53 and TGF-β1/Smad2/3 pathways 2020 ·Biomedicine & Pharmacotherapy ·Zhiqing Shen,(unknown),(unknown),Xiangyan Wu,Jianfeng Chu,Ying Cheng,(unknown),Youqin Chen,Nathaniel Weygant,Meizhu Wu,Xiaoying Lin,Jun Peng,Keji Chen	18
9	DCLK1 Regulates Tumor Stemness and Cisplatin Resistance in Non-small Cell Lung Cancer via ABCD-Member-4 2020 ·Molecular Therapy — Oncolytics ·Janani Panneerselvam,(unknown),Ravi B. Patel,(unknown),Michael Li,(unknown),(unknown),Nathaniel Weygant,Dongfeng Qu,(unknown),Stanley Lightfoot,Chinthalapally V. Rao,Courtney W. Houchen,Michael S. Bronze,Parthasarathy Chandrakesan	34
10	A novel integrated system using patient-derived glioma cerebral organoids and xenografts for disease modeling and drug screening 2020 ·Cancer Letters ·Liyang Zhang,Fangkun Liu,Nathaniel Weygant,Junxia Zhang,Ping Hu,Zailong Qin,Jingxuan Yang,Quan Cheng,Fan Fan,Yu Zeng,(unknown),Yusheng Li,Anliu Tang,(unknown),Jun Peng,Weihua Liao,Zhongliang Hu,Min Li,Zhixiong Liu	44
11	Differential risks of immune-related colitis among various immune checkpoint inhibitor regimens 2020 ·International Immunopharmacology ·Jiannan Yao,Manyu Li,Huiyun Zhang,Yang Ge,Nathaniel Weygant,Guangyu An	13
12	The role of sex in the innate and adaptive immune environment of metastatic colorectal cancer 2020 ·British Journal of Cancer ·(unknown),Robert A. Nofchissey,Maaz Khan,(unknown),Megan R. Lerner,Xiangyan Wu,(unknown),(unknown),Nathaniel Weygant,Sarah F. Adams,Eliseo F. Castillo,William L. Berry,Michael B. Stout,Katherine T. Morris	22
13	Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem–like Cells Marked by DCLK1 Kinase 2016 ·Cancer Research ·Nathaniel Weygant,Yang Ge,Dongfeng Qu,John S. Kaddis,William L. Berry,Randal May,Parthasarathy Chandrakesan,(unknown),Kenneth J. Vega,James J. Tomasek,Michael S. Bronze,Guangyu An,Courtney W. Houchen	28
14	Intestinal tuft cells regulate the ATM mediated DNA Damage response via Dclk1 dependent mechanism for crypt restitution following radiation injury 2016 ·Scientific Reports ·Parthasarathy Chandrakesan,Randal May,Nathaniel Weygant,Dongfeng Qu,William L. Berry,Sripathi M. Sureban,Naushad Ali,Chinthalapally V. Rao,Mark M. Huycke,Michael S. Bronze,Courtney W. Houchen	36
15	Ablation of Doublecortin-Like Kinase 1 in the Colonic Epithelium Exacerbates Dextran Sulfate Sodium-Induced Colitis 2015 ·PLoS ONE ·Dongfeng Qu,Nathaniel Weygant,Randal May,Parthasarathy Chandrakesan,Mohammad F. Madhoun,Naushad Ali,Sripathi M. Sureban,Guangyu An,Michael Schlosser,Courtney W. Houchen	56
16	XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism 2014 ·Cancer Letters ·Sripathi M. Sureban,Randal May,Nathaniel Weygant,Dongfeng Qu,Parthasarathy Chandrakesan,(unknown),Naushad Ali,Panayotis Pantazis,C. Benedikt Westphalen,Timothy C. Wang,Courtney W. Houchen	103
17	Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1 2014 ·Molecular Cancer ·Nathaniel Weygant,Dongfeng Qu,William L. Berry,Randal May,Parthasarathy Chandrakesan,Daniel B. Owen,Sripathi M. Sureban,Naushad Ali,Ralf Janknecht,Courtney W. Houchen	92
18	Correction: Fluvastatin Interferes with Hepatitis C Virus Replication via Microtubule Bundling and a Doublecortin-like Kinase-Mediated Mechanism 2013 ·PLoS ONE ·Naushad Ali,(unknown),Ted Bader,Randal May,Kanthesh M. Basalingappa,William L. Berry,Parthasarathy Chandrakesan,Dongfeng Qu,Nathaniel Weygant,Michael S. Bronze,Shahid Umar,Ralf Janknecht,Sripathi M. Sureban,Mark M. Huycke,Courtney W. Houchen	8
19	Fluvastatin Interferes with Hepatitis C Virus Replication via Microtubule Bundling and a Doublecortin-like Kinase-Mediated Mechanism 2013 ·PLoS ONE ·Naushad Ali,(unknown),Ted Bader,Randal May,Kanthesh M. Basalingappa,William L. Berry,Parthasarathy Chandrakesan,Dongfeng Qu,Nathaniel Weygant,Michael S. Bronze,Shahid Umar,Ralf Janknecht,Sripathi M. Sureban,Mark M. Huycke,Courtney W. Houchen	26
20	Identification of the putative intestinal stem cell marker doublecortin and CaM kinase‐like‐1 in Barrett's esophagus and esophageal adenocarcinoma 2011 ·Journal of Gastroenterology and Hepatology ·Kenneth J. Vega,Randal May,Sripathi M. Sureban,Stan Lightfoot,Dongfeng Qu,(unknown),Nathaniel Weygant,Rama P. Ramanujam,Rhonda F. Souza,Mohammad F. Madhoun,(unknown),Shrikant Anant,Stephen J. Meltzer,Courtney W. Houchen	59

About Nathaniel Weygant

Nathaniel Weygant is a scholar working on Oncology, Cancer Research and Hepatology, having authored 55 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (25 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Cancer Genomics and Diagnostics (7 papers). The work is most often cited by research in Oncology (753 citations), Cancer Research (358 citations) and Cell Biology (301 citations). Nathaniel Weygant has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Dongfeng Qu, Courtney W. Houchen, Parthasarathy Chandrakesan, Randal May, Sripathi M. Sureban, Naushad Ali, William L. Berry, Stan Lightfoot, Michael S. Bronze and Jun Peng. Their work appears in journals such as Gastroenterology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact